AI Article Synopsis
- A 70-year-old woman was diagnosed with advanced esophageal cancer (Stage III) and received 2 rounds of neoadjuvant chemotherapy before undergoing curative surgery with lymph node dissection.
- After surgery, she developed liver metastasis, which was treated with stereotactic body radiation therapy (SBRT), showing good local control without serious side effects.
- Following SBRT, she was given systemic chemotherapy and experienced no recurrence for 12 months, indicating that SBRT is an effective option for treating liver metastases in esophageal cancer patients.
Article Abstract
A 70-year-old woman was diagnosed as having advanced lower thoracic esophageal cancer with abdominal lymph node metastases(T3N1M0, Stage III). After administering 2 courses of neoadjuvant chemotherapy with 5-fluorouracil(5- FU)( 800 mg/m2)and cisplatin(80 mg/m2), we performed curative surgery with D2 lymph node dissection. The patient could not receive adjuvant chemotherapy because of her poor performance status. After curative surgery, liver metastasis appeared in segment 8. The liver metastasis(S8)was treated with stereotactic body radiation therapy(SBRT)( 60 Gy/3 Fr). After SBRT, we administered systemic chemotherapy with docetaxel and nedaplatin as second-line chemotherapy. The patient had no recurrence for 12 months after SBRT. SBRT exhibited an excellent local therapeutic effect without any serious complications, suggesting that it is an effective treatment for liver metastasis from esophageal cancer.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!